cemacabtagene ansegedleucel
ALLO-501A-202
Phase 2 gene_therapy active
Quick answer
cemacabtagene ansegedleucel for Large B-cell Lymphoma is a Phase 2 program (gene_therapy) at Allogene Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Allogene Therapeutics
- Indication
- Large B-cell Lymphoma
- Phase
- Phase 2
- Modality
- gene_therapy
- Status
- active